Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Interferon-alpha2a vs Cyclosporin A in Ocular Behcet's Disease
NCT00167583Phase 3Completed
- Sponsor
- University Hospital Tübingen
- Start
- Nov 2004
- Primary completion
- Dec 2014
- Modality
- rProtein (Recombinant Protein), Biologic
- Countries
- 1
01
Overview
A Phase 3 trial of interferon alfa-2a in Behcet's disease (BD), sponsored by University Hospital Tübingen. Started Nov 2004; status: completed.
02
Drugs
interferon alfa-2a
03
Conditions
Behcet's disease (BD)
Beyond the preview
Go deeper on NCT00167583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00167583.